Medical Writing Preclinical Studies How to survive Brexit as an independent medical writer

Volume 26, Issue 4 - Preclinical Studies

How to survive Brexit as an independent medical writer


While Brexit has brought about a period of uncertainty in the UK’s pharmaceutical industry, what is an appropriate response by medical writers at such a time? Few successful businesses stand idle and wait for things to  happen. Taking a look at the current climate of outsourcing and the UK’s business environment in terms of investment, now may be the time for writers to consider their strengths and weaknesses, diversifying their portfolio, and being strategic in seeking a competitive advantage.
Download the full article


  1. Cumming DJ, Zahra SA. International business and entrepreneurship implications of Brexit. Brit J Manage. 2016;27:687–92. Available from: http://
  2. The Telegraph. Big pharma will pull out of Britain unless we start paying for new drugs, warns AstraZeneca. 2016 [cited 2017 Aug 12]. Available from: 2016/10/31/big-pharma-will-pull-out-ofbritain- unless-we-start-paying-for-n/
  3. Loewendahl H. The impact of Brexit on foreign direct investment into the UK: recommendations for investment promotion strategy [Working Paper]. WAVTEQ; 2016 [cited 12 July 2017]. Available from: brexit
  4. Suchak N. Life sciences: Times of political uncertainty [Internet]. The Recruitment and Employment Confederation; 2017 [cited 10 August 2017]. Available from: corporate-blog/life-sciences-timesof- political-uncertainty
  5. Nicholls A. Brexit – what’s next for pharma? PharmaTimes Mag. 2017;July&August: 24-5. [cited 10 August 2017]. Available from: http://www. magazine/2016/july_2016/smartviews_ brexit_-_whats_next_ for_pharma
  6. Murdoch B. Brexit – a bitter pill for the pharma industry? [Internet]. Adents; 2017 [cited 2017 Aug 17]. Available from: fmd-compliance- 1417.html
  7. TOPRA. Brexit. 2017 [cited 1 September 2017]. Available from: Member/Brexit_folder/brexit_home.aspx
  8. European Medicines Agency. Statement on the outcome of the UK referendum. 2017 [cited 1 September 2017]. Available from: ?curl=pages/news_and_events/news/ 2016/07/news_detail_002566.jsp&mid= WC0b01ac058004d5c1
  9. Bressler M. How small businesses master the art of competition through superior competitive advantage. J Manage Marketing Res. 2012;2–9. Available from: http://
  10. Winer RS. Marketing management. New Jersey: Prentice Hall Publishing; 2004. Available from: http://
  11. Sharma B. Brexit strategy for small businesses. KPMG Small Business Accounting; 2016 [cited 2017 August 16]. Available from: uploads/2016/08/CRT055619_ Brexit-Blogs-Guide_v7.pdf



Preclinical studies
President’s Message
EMWA celebrates 25 years
Preclinical research in drug development
An introduction to little-known aspects of nonclinical regulatory writing
Reporting of preclinical research: What do we get told – when and how?
Mind the gap – towards complete and transparent reporting of animal research
The reproducibility crisis in preclinical research – lessons to learn from clinical research
Nonclinical studies in the Russian Federation — Problems, regulatory norms, and harmonisation with international standards
How to survive Brexit as an independent medical writer
Creation of a patient-centric patient lay summary in the local language
Six communication rules for scientific presentations and writing
So, you want to be a medical journalist?
News from the EMA
Profile: An interview with Steven Walker
Getting Your Foot in the Door
In the Bookstores
Journal Watch
The Webscout
Good Writing Practice
Medical Communications
Out on Our Own

Member Login


The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board



Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: